PP01.58 Real-world outcomes in patients with EGFR wildtype non-squamous locally advanced/metastatic NSCLC receiving second- or third-line docetaxel: Pooled analysis from LUMINATE-101

2023

Girard N, Xu Q, Camidge DR, Baijal S, Karve S, Ng S, Kamalakar R, Ratajczak C, Allen A, Lu S